Noxalk (150 mg.)

NATCO PHARMA LIMITED (INDIA)

“Noxalk” contains Drug / Molecule called “Ceritinib”.  Noxalk is an anaplastic lymphoma kinase (ALK) positive inhibitor primarily used for the treatment of metastatic NSCLC. Noxalk thus acts to inhibit mutated enzyme and stop cell proliferation, ultimately halting cancer progression.

Category:

Indication

Noxalk is used for the treatment of non-small cell lung cancer.

Note

Precaution

  • Noxalk is a prescription drug and should be used under proper medical guidance and advice.
  • Noxalk may cause severe, life-threatening or fatal interstitial lung disease / pneumonitis.

Related products